ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
286K |
71 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
924
|
286K
|
71
|
|
ASX - By Stock
|
RAC |
CPACS: Research, Results, Market Comparisons, and Valuations
|
|
Mason14
|
307 |
97K |
130 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
307
|
97K
|
130
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
286K |
15 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
924
|
286K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
86K |
52 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
391
|
86K
|
52
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
86K |
44 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
86K
|
44
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
86K |
52 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
86K
|
52
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
86K |
40 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
86K
|
40
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
86K |
43 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
86K
|
43
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
86K |
43 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
86K
|
43
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
86K |
35 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
86K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
86K |
61 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
86K
|
61
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
86K |
37 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
86K
|
37
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
86K |
39 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
86K
|
39
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
12K |
4.2M |
106 |
10/07/24 |
10/07/24 |
General
|
12K
|
4.2M
|
106
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
86K |
23 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
86K
|
23
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
86K |
66 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
86K
|
66
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
86K |
35 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
391
|
86K
|
35
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
12K |
4.2M |
73 |
09/07/24 |
09/07/24 |
General
|
12K
|
4.2M
|
73
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Mason14
|
12K |
4.2M |
91 |
09/07/24 |
09/07/24 |
General
|
12K
|
4.2M
|
91
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
86K |
66 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
86K
|
66
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Mason14
|
391 |
86K |
9 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
391
|
86K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Mason14
|
16K |
7.7M |
10 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
16K
|
7.7M
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Mason14
|
16K |
7.7M |
2 |
06/07/24 |
06/07/24 |
ASX - By Stock
|
16K
|
7.7M
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial
|
|
Mason14
|
71 |
27K |
10 |
06/07/24 |
06/07/24 |
ASX - By Stock
|
71
|
27K
|
10
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Azer Cell Toxicity from Ken
|
|
Mason14
|
86 |
33K |
4 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
86
|
33K
|
4
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Azer Cell Toxicity from Ken
|
|
Mason14
|
86 |
33K |
18 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
86
|
33K
|
18
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Azer Cell Toxicity from Ken
|
|
Mason14
|
86 |
33K |
18 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
86
|
33K
|
18
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Azer Cell Toxicity from Ken
|
|
Mason14
|
86 |
33K |
15 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
86
|
33K
|
15
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Azer Cell Toxicity from Ken
|
|
Mason14
|
86 |
33K |
14 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
86
|
33K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
27K |
13M |
7 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
27K
|
13M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
Mason14
|
168 |
49K |
121 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
168
|
49K
|
121
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
27K |
13M |
14 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
27K
|
13M
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
27K |
13M |
20 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
27K
|
13M
|
20
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
Mason14
|
130 |
40K |
44 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
130
|
40K
|
44
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
27K |
13M |
13 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
27K
|
13M
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
27K |
13M |
24 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
27K
|
13M
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Mason14
|
27K |
13M |
13 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
27K
|
13M
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
286K |
70 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
924
|
286K
|
70
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
286K |
77 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
924
|
286K
|
77
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Mason14
|
3.0K |
1.0M |
47 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
3.0K
|
1.0M
|
47
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
286K |
208 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
924
|
286K
|
208
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
286K |
35 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
924
|
286K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
286K |
16 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
924
|
286K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
286K |
62 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
924
|
286K
|
62
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
286K |
35 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
924
|
286K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
286K |
47 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
924
|
286K
|
47
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
286K |
72 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
924
|
286K
|
72
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Mason14
|
924 |
286K |
137 |
22/06/24 |
22/06/24 |
ASX - By Stock
|
924
|
286K
|
137
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Mason14
|
22K |
8.0M |
56 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
22K
|
8.0M
|
56
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Mason14
|
2.3K |
791K |
26 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
2.3K
|
791K
|
26
|
|